ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

XENE Xenon Pharmaceuticals Inc

37,25
-0,79 (-2,08%)
15 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Xenon Pharmaceuticals Inc XENE NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,79 -2,08% 37,25 01:00:11
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
37,75 36,55 38,04 37,25 38,04
mais cotações »

Notícias Recentes

Data Hora Fonte Título
05/06/202417:01GLOBEXenon Pharmaceuticals to Present at the Goldman Sachs 45th..
28/05/202409:30GLOBEXenon Pharmaceuticals Presents Data from Phase 2 X-NOVA..
09/05/202417:01GLOBEXenon Pharmaceuticals Reports First Quarter 2024 Financial..
08/05/202417:01GLOBEXenon Pharmaceuticals to Present at the BofA Securities..
07/05/202417:01GLOBEXenon Pharmaceuticals to Present at the 2024 RBC Capital..
02/05/202417:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
16/04/202409:30GLOBEXenon Pharmaceuticals Showcases XEN1101 at the American..
04/04/202417:01GLOBEXenon Pharmaceuticals to Present at the 23rd Annual Needham..
12/03/202417:01GLOBEXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
05/03/202418:01GLOBEXenon Pharmaceuticals to Present at Leerink Partners Global..
29/02/202418:01GLOBEXenon Pharmaceuticals Reports Fourth Quarter and Full Year..
22/02/202418:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
08/01/202410:00GLOBEXenon Pharmaceuticals Outlines Key Milestone Opportunities..
03/01/202410:30GLOBEXenon Pharmaceuticals to Present at the 42nd Annual J.P...
04/12/202318:16GLOBEXenon Pharmaceuticals Announces Closing of $345.0 Million..
02/12/202314:01GLOBEXenon Pharmaceuticals Provides Updates on Neurology Pipeline..
30/11/202300:51GLOBEXenon Pharmaceuticals Announces Pricing of Upsized $300.0..
29/11/202318:03GLOBEXenon Pharmaceuticals Announces Proposed Public Offering
27/11/202309:00GLOBEXenon Pharmaceuticals Announces Topline Results from Phase 2..
09/11/202318:03GLOBEXenon Pharmaceuticals Provides Update on Partnered Program..
08/11/202318:01GLOBEXenon Pharmaceuticals Reports Third Quarter 2023 Financial..
01/11/202317:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
09/10/202317:15GLOBEXenon Pharmaceuticals Announces Publication of Results from..
06/10/202309:30GLOBEXenon Pharmaceuticals to Present at Jefferies Inaugural..
14/09/202317:01GLOBEXenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual..
12/09/202317:30GLOBEXenon Pharmaceuticals Announces Upcoming Investor Webinar..
04/09/202309:30GLOBEXenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at..
31/08/202317:01GLOBEXenon Pharmaceuticals to Present at the Wells Fargo 2023..
09/08/202317:01GLOBEXenon Pharmaceuticals Reports Second Quarter 2023 Financial..
08/08/202317:01GLOBEXenon Pharmaceuticals Expands Leadership on its Board of..
02/08/202317:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..